4th PEPTIDES EVENT
06 July 2017 - 07 July 2017
SMi’s 4th annual Peptides conference will take place on 6 & 7 July 2017 in London.
Peptide manufacturers and suppliers have been developing and implementing new technologies to improve the peptide production, reduce manufacturing costs, and allow for more accurate formulations to enhance overall drug delivery. In addition, as cancer has been the most prominent sector in peptide therapeutics and is further expected to stay at the top, the market has been largely driven by the increased demand for peptides in cancer treatment. The increase in collaborations between biotech companies has also contributed to the market growing at this rate. The conference will provide a platform for attendees to gather valuable new insight on assessing biophysical characterization, extending half-life, new formulations and routes of administration, and other pressing matters in the peptides industry.
Thus this year’s conference will include presentations from key industry professionals who will discuss and deliberate themes including peptide formulation and delivery, as well as new advances in alternative peptide analysis technologies, Cell Penetrating Peptides, enhancements in synthesis mechanisms, analytical monitoring techniques, and more.
New speakers include UCB, Nestle Skin Health, Boehringer Ingelheim, Pfizer, Ferring, Sanofi, Novartis, BMS, Ipsen and more.
The complete agenda can be viewed on https://www.smi-online.co.uk/pharmaceuticals/uk/Peptides
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/Peptides
4th Annual Allergies
06 July 2017 - 07 July 2017
SMi’s 4th annual allergies conference is set to take place this Summer in London. Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2017 will provide an interactive platform , enabling discussion focused on pioneering clinical developments and the next generation of allergy therapeutics. Delegates will be able to align their product portfolio to therapeutic areas with high growth potential and devise a more tailored strategy through the understanding of key drivers.
Holiday Inn Kensington Forum, London, UK
http://www.allergies-event.com/drugdiscovery
7th Annual International Symposium of Drug Delivery Systems - 2017
12 July 2017 - 14 July 2017
SDDS-2017 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the poster sessions will also take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Vienna House Diplomat Prague, Czech Republic
http://www.bitcongress.com/sdds2017/default.asp
Anti-Infectives Partnering & Deal-Making
13 July 2017 - 14 July 2017
We are excited to announce the 14th Anti-Infectives Partnering & Deal-Making Conference, which will take place July 13-14, 2017 in Baltimore, MD. Recently launched programs such as CARB-X and the expanded pool of research and development funds brought about by the U.S. National Action Plans on Combating Antibiotic Resistant Bacteria (CARB) demonstrate recognition that the anti-infective pipeline is precariously fragile. These complimentary programs, as well as other international programs, seek to address funding and market limitations that occur at all phases of drug development, from early stage, hit to lead identification, to late stage clinical development. However, despite the technical and monetary resources available to developers the challenges and risks inherent in anti-infective development loom unabated.
We invite you to join us for this two day event as we discuss the types and availability of economic incentives to spur innovation and development of therapies to address rapidly emerging global health threats; international partnering and funding opportunities; and non-traditional approaches and technologies, including innovative clinical trial strategies for the development of anti-infectives. Over the course of this meeting attendees will have ample opportunity to engage and network with speaker and panelists.
Royal Sonesta Harbor Court Baltimore, MD, USA
https://www.gtcbio.com/conferences/anti-infectives-partnering-deal-making/
Infectious Diseases Summit
13 July 2017 - 14 July 2017
We are pleased to invite you to attend GTCbio’s Infectious Diseases Summit, which will take place July 13-14, 2017 in Baltimore, MD. This event seeks to provide a forum for leaders to get the most comprehensive and wide-reaching perspective on issues, challenges, and advances in the field.
The Summit begins with the Plenary Session: Rapidly Emerging Global Health Threats and disperses into the following three conferences:
6th Antiviral Drugs Research & Development
I. Respiratory Virus Infections
II. Treatment of Latent and Persistent Viral Infections
III. Regulatory Challenges on Clinical Study Design and Considerations
15th Vaccines Research & Development
I. Next-Generation Vaccine Technologies
II. Vaccines for Infectious Diseases-Old & New Challenges
III. Enhancing Immunity at Both Ends of the Age Spectrum
IV. Panel: Clinical Trial Design During Epidemics
14th Anti-Infectives Partnering & Deal-Making
I. Non-Traditional Approaches and Technologies in Anti-Infectives
II. Innovative Strategies in Clinical Trials
III. Panel: Funding & Partnering with US Government Agencies
IV. Panel: Pricing and P&T Committee’s Role in Determining Novel Antibiotic Usage
V. Panel: Pushing and Pulling: What Incentives Help Spark Innovation in Antibiotic Drug Discovery and Development?
The end of the Summit comes together with the General Session: Public/Private Partnerships in Support of Global Health.
Royal Sonesta Harbor Court Baltimore, MD, USA
https://www.gtcbio.com/conferences/infectious-diseases-summit/
5th Annual Tumor Models Boston
18 July 2017 - 20 July 2017
The 5th Annual Tumor Models Boston continues to showcase the latest advancements in the application of preclinical models to enhance the translation of cancer therapies from animal to patient. Learn how the industry have been selecting & characterizing in vitro models, ex vivo assays, syngeneic models, PDX, humanized mice models to optimize their application in preclinical and translational studies for targeted therapies, cancer immunotherapies and combination therapies. Uncover the valuable clinical lessons that are helping to transform preclinical research through reverse translation and to extract more value from preclinical models to enhance preclinical and translational decision making into the clinic.
Discover lessons from the clinic to progress future cancer treatments into the clinic more effectively and faster.
The Colonnade Hotel, 120 Huntington Avenue, MA, 02116, USA
http://tumor-models.com/about/brochure/